What Tvardi Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Tweardy Samuel David | 10% owner | Jul 07 | Other Transaction · J | −315,658 | — | — | 0 |
| Tweardy Samuel David | 10% owner | Jul 07 | Other Transaction · J | −315,658 | — | — | 0 |
| Wirk Shaheen | Director | Apr 15 | Grant / award · A | +263,164 | — | — | 263,164 |
| Wirk Shaheen | Director | Apr 15 | Grant / award · A | +176,030 | — | — | 176,030 |
| Hall Wallace L Jr | Director | Apr 15 | Grant / award · A | +202,044 | — | — | 202,044 |
| Hall Wallace L Jr | Director | Apr 15 | Grant / award · A | +44,712 | — | — | 44,712 |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | Feb 28 | Open-market sale · S | −163 | $4.76 | −$776 | 7,190 |
| Posner Christopher | PRESIDENT AND CEO | Feb 28 | Open-market sale · S | −583 | $4.75 | −$2.77K | 13,109 |
| Posner Christopher | PRESIDENT AND CEO | Feb 04 | Open-market sale · S | −372 | $4.72 | −$1.76K | 13,692 |
| Posner Christopher | PRESIDENT AND CEO | Nov 04 | Open-market sale · S | −3,668 | $0.29 | −$1.06K | 168,768 |
| Posner Christopher | PRESIDENT AND CEO | Aug 01 | Open-market sale · S | −4,149 | $0.35 | −$1.45K | 172,436 |
| Boudreau Helen M | Director | Jun 04 | Grant / award · A | +150,647 | — | — | 150,647 |
| Vogelbaum Martin | Director | Jun 04 | Grant / award · A | +301,295 | — | — | 411,007 |
| Shiff Susan Ph.D. | Director | Jun 04 | Grant / award · A | +150,647 | — | — | 202,085 |
| Ives Jeffrey L. | Director | Jun 04 | Grant / award · A | +150,647 | — | — | 198,485 |
| von Moltke Lisa | Director | Jun 04 | Grant / award · A | +150,647 | — | — | 183,009 |
| Posner Christopher | PRESIDENT AND CEO | May 02 | Open-market sale · S | −3,936 | $0.75 | −$2.95K | 176,585 |
| Goncalves Joana | CHIEF MEDICAL OFFICER | Apr 05 | Open-market sale · S | −2,753 | $0.83 | −$2.28K | 53,365 |
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | Apr 05 | Open-market sale · S | −2,753 | $0.83 | −$2.28K | 88,247 |
| Goncalves Joana | CHIEF MEDICAL OFFICER | Feb 29 | Open-market sale · S | −3,293 | $0.89 | −$2.93K | 56,118 |
Loading...
